Publication not explained
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
Featured Image
Read the Original
This page is a summary of: Development and validation of a versatile HPLC-DAD method for simultaneous determination of the antiviral drugs daclatasvir, ledipasvir, sofosbuvir and ribavirin in presence of seven potential impurities. Application to assay of dosage forms and dissol..., Drug Development and Industrial Pharmacy, April 2019, Taylor & Francis,
DOI: 10.1080/03639045.2019.1593444.
You can read the full text:
Contributors
The following have contributed to this page
